ENLIE Pharmaceutical JSC (HSTC:BCP) Debt-to-Asset : 0.00 (As of . 20)

View and export this data going back to 2015. Start your Free Trial

What is ENLIE Pharmaceutical JSC Debt-to-Asset?

ENLIE Pharmaceutical JSC's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. ENLIE Pharmaceutical JSC's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. ENLIE Pharmaceutical JSC's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in . 20 was ₫0.00 Mil.

ENLIE Pharmaceutical JSC Debt-to-Asset Historical Data

The historical data trend for ENLIE Pharmaceutical JSC's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ENLIE Pharmaceutical JSC Debt-to-Asset Chart

ENLIE Pharmaceutical JSC Annual Data

Trend

Debt-to-Asset

ENLIE Pharmaceutical JSC Semi-Annual Data

Debt-to-Asset

Competitive Comparison of ENLIE Pharmaceutical JSC's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, ENLIE Pharmaceutical JSC's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ENLIE Pharmaceutical JSC's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ENLIE Pharmaceutical JSC's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where ENLIE Pharmaceutical JSC's Debt-to-Asset falls into.

ENLIE Pharmaceutical JSC Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

ENLIE Pharmaceutical JSC's Debt-to-Asset for the fiscal year that ended in . 20 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(	+	)	/
	=	N/A

ENLIE Pharmaceutical JSC's Debt-to-Asset for the quarter that ended in . 20 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(	+	)	/
	=	N/A

ENLIE Pharmaceutical JSC (HSTC:BCP) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

ENLIE Pharmaceutical JSC Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of ENLIE Pharmaceutical JSC's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

ENLIE Pharmaceutical JSC (HSTC:BCP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ENLIE Pharmaceutical JSC (HSTC:BCP) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

NA6 Street, My Phuoc 2 Industrial Park, Ben Cat district, Binh Duong, VNM

Website

http://www.enlie.vn

ENLIE Pharmaceutical JSC is engaged in the production and trading of pharmaceuticals, medical supplies, cosmetics, foods, and functional foods. It is also engaged in the wholesale of other installation materials and equipment in the construction.

ENLIE Pharmaceutical JSC (HSTC:BCP) Headlines

No Headlines